Caroline E Nunes-Xavier Selected Research

6-pyruvoyltetrahydropterin synthase (PTPS)

1/2021	Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets.
12/2019	Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma.
1/2019	The role of protein tyrosine phosphatases in prostate cancer biology.
1/2016	The Extended Family of Protein Tyrosine Phosphatases.
12/2013	Protein tyrosine phosphatases as novel targets in breast cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caroline E Nunes-Xavier Research Topics

Disease

17	Neoplasms (Cancer) 11/2021 - 01/2012
4	Neuroblastoma 01/2021 - 12/2018
4	Breast Neoplasms (Breast Cancer) 02/2016 - 08/2010
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2016
2	Carcinoma (Carcinomatosis) 11/2021 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2019 - 01/2017
1	Carcinogenesis 01/2022
1	Medulloblastoma 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Adenocarcinoma 01/2021
1	Homocystinuria 04/2020
1	Methylmalonic acidemia 04/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Triple Negative Breast Neoplasms 02/2016
1	Lymphatic Metastasis 01/2016
1	Metabolic Diseases (Metabolic Disease) 01/2016

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
5	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2021 - 12/2013
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
4	Protein Tyrosine PhosphatasesIBA 01/2021 - 12/2013
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
3	Everolimus FDA Link 01/2022 - 02/2016
3	Immune Checkpoint ProteinsIBA 01/2022 - 01/2020
3	Biological ProductsIBA 12/2019 - 01/2016
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
2	MTOR InhibitorsIBA 01/2022 - 02/2016
2	EnzymesIBA 01/2020 - 05/2014
2	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 12/2019 - 01/2019
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 08/2010
2	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 01/2017
2	API 2IBA 01/2017 - 02/2016
2	Tyrosine (L-Tyrosine)FDA Link 12/2013 - 01/2012
1	CateninsIBA 01/2022
1	cabozantinibIBA 01/2022
1	temsirolimus FDA Link 01/2022
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Axitinib (AG 013736)IBA 01/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 01/2022
1	lenvatinibIBA 01/2022
1	Prorenin ReceptorIBA 11/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2020
1	AntibodiesIBA 12/2019
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 12/2019
1	Dual-Specificity PhosphatasesIBA 03/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	PhosphotyrosineIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	EpitopesIBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2018
1	Monoclonal AntibodiesIBA 01/2017
1	VemurafenibIBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	binimetinibIBA 01/2017
1	Serine (L-Serine)FDA Link 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2013
1	ErbB Receptors (EGF Receptor)IBA 01/2012
1	Class 4 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2012
1	Phorbol EstersIBA 08/2010
1	Phosphotransferases (Kinase)IBA 08/2010
1	phorbolIBA 08/2010

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2013
2	Immunotherapy 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2017
1	Aftercare (After-Treatment) 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2019
1	Cystectomy 01/2019